b

biote Corp
NASDAQ:BTMD

Watchlist Manager
biote Corp
NASDAQ:BTMD
Watchlist
Price: 6.57 USD -2.23% Market Closed
Market Cap: 356.2m USD
Have any thoughts about
biote Corp?
Write Note

biote Corp
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

biote Corp
Revenue Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
b
biote Corp
NASDAQ:BTMD
Revenue
$185.4m
CAGR 3-Years
17%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Revenue
$87.7B
CAGR 3-Years
-1%
CAGR 5-Years
1%
CAGR 10-Years
2%
Bristol-Myers Squibb Co
NYSE:BMY
Revenue
$47.4B
CAGR 3-Years
1%
CAGR 5-Years
14%
CAGR 10-Years
11%
Pfizer Inc
NYSE:PFE
Revenue
$60.1B
CAGR 3-Years
-4%
CAGR 5-Years
14%
CAGR 10-Years
2%
Merck & Co Inc
NYSE:MRK
Revenue
$63.2B
CAGR 3-Years
11%
CAGR 5-Years
7%
CAGR 10-Years
4%
Eli Lilly and Co
NYSE:LLY
Revenue
$40.9B
CAGR 3-Years
14%
CAGR 5-Years
13%
CAGR 10-Years
7%

biote Corp
Revenue Breakdown

Breakdown by Geography
biote Corp

Total Revenue: 185.4m USD
100%
United States: 181.8m USD
98.1%
All Other Country: 735k USD
0.4%

Breakdown by Segments
biote Corp

Total Revenue: 185.4m USD
100%
Product Revenue: 182.6m USD
98.5%
Dietary Supplements: 38.1m USD
20.5%
Service Revenue: 2.8m USD
1.5%
Training Service Revenue: 1.2m USD
0.6%
Other Service Revenue: 697k USD
0.4%
Show More
Show Less

See Also

What is biote Corp's Revenue?
Revenue
185.4m USD

Based on the financial report for Dec 31, 2023, biote Corp's Revenue amounts to 185.4m USD.

What is biote Corp's Revenue growth rate?
Revenue CAGR 3Y
17%

Over the last year, the Revenue growth was 12%. The average annual Revenue growth rates for biote Corp have been 17% over the past three years .

Back to Top